ZCCHC4 and cancer: Here, we revealed an important role for a rarely studied RBP--ZCCHC4 in promoting HCC chemoresistance, and identified ZCCHC4 as a new predictor of cancer poor prognosis and a potential target for improving chemotherapy effects in cancer patients.